B-Cell CLL-Lymphoma 10 Protein
"B-Cell CLL-Lymphoma 10 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A signal transducing adaptor protein that contains an N-terminal CARD DOMAIN and functions in the ADAPTIVE IMMUNE RESPONSE. It promotes PRO-CASPASE-9 maturation and APOPTOSIS, activation of NF-KAPPA B, and is a substrate for MALT1 PARACASPASE.
| Descriptor ID |
D000074018
|
| MeSH Number(s) |
D12.644.360.024.131.140 D12.644.360.075.358.140 D12.776.157.057.006.140 D12.776.476.024.139.140 D12.776.476.075.358.140
|
| Concept/Terms |
B-Cell CLL-Lymphoma 10 Protein- B-Cell CLL-Lymphoma 10 Protein
- B Cell CLL Lymphoma 10 Protein
- Bcl-10 Protein
- Bcl 10 Protein
- B-Cell Lymphoma-Leukemia 10 Protein
- B Cell Lymphoma Leukemia 10 Protein
- Bcl10 Protein
|
Below are MeSH descriptors whose meaning is more general than "B-Cell CLL-Lymphoma 10 Protein".
Below are MeSH descriptors whose meaning is more specific than "B-Cell CLL-Lymphoma 10 Protein".
This graph shows the total number of publications written about "B-Cell CLL-Lymphoma 10 Protein" by people in this website by year, and whether "B-Cell CLL-Lymphoma 10 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "B-Cell CLL-Lymphoma 10 Protein" by people in Profiles.
-
BCL10 in cell survival after DNA damage. Clin Chim Acta. 2019 Aug; 495:301-308.
-
CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection. Cell Rep. 2016 Mar 15; 14(10):2389-401.
-
The CBM Complex Underwrites NF-?B Activation to Promote HER2-Associated Tumor Malignancy. Mol Cancer Res. 2016 Jan; 14(1):93-102.
-
C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-?B activation. J Biol Chem. 2014 Oct 24; 289(43):30052-62.
-
Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity. 2014 May 15; 40(5):692-705.
-
The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity. Cell Host Microbe. 2012 Mar 15; 11(3):277-89.
-
CARMA3 is crucial for EGFR-Induced activation of NF-?B and tumor progression. Cancer Res. 2011 Mar 15; 71(6):2183-92.
-
Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. J Immunol. 2009 Jan 15; 182(2):1146-54.
-
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009 Mar 05; 458(7234):92-6.
-
Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. Mol Cell Biol. 2007 Jul; 27(14):5235-45.